glutaral has been researched along with clodronic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baldassari, S; Bassi, AM; Caviglioli, G; Croce, I; Gaglianone, N; Parodi, B; Russo, E; Vernazza, S | 1 |
Dong, N; Li, F; Liu, X; Liu, Z; Wang, Y; Xie, F | 1 |
2 other study(ies) available for glutaral and clodronic acid
Article | Year |
---|---|
Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration.
Topics: Bone Density Conservation Agents; Cell Line; Cell Survival; Clodronic Acid; Collagen; Cross-Linking Reagents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Durapatite; Factor Analysis, Statistical; Gene Expression; Glutaral; Humans; Interleukin-1beta; Interleukin-8; Monocytes; Nanoparticles; Particle Size; Phase Transition; Poloxamer; Viscosity | 2016 |
Elimination of macrophages reduces glutaraldehyde-fixed porcine heart valve degeneration in mice subdermal model.
Topics: Animals; Aortic Valve; Bioprosthesis; Calcinosis; Calcium; Cell Differentiation; Clodronic Acid; Cytokines; Fixatives; Glutaral; Heart Valve Prosthesis; Liposomes; Macrophages, Peritoneal; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Osteoblasts; Prosthesis Failure; Swine; T-Lymphocytes | 2021 |